Suppr超能文献

孕期对乙酰氨基酚的使用与神经发育:注意力功能和自闭症谱系症状

Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms.

作者信息

Avella-Garcia Claudia B, Julvez Jordi, Fortuny Joan, Rebordosa Cristina, García-Esteban Raquel, Galán Isolina Riaño, Tardón Adonina, Rodríguez-Bernal Clara L, Iñiguez Carmen, Andiarena Ainara, Santa-Marina Loreto, Sunyer Jordi

机构信息

Center for Research in Environmental Epidemiology (CREAL).

Unitat Docent de Medicina Preventiva i Salut Publica H. Mar-UPF-ASPB.

出版信息

Int J Epidemiol. 2016 Dec 1;45(6):1987-1996. doi: 10.1093/ije/dyw115.

Abstract

BACKGROUND

Acetaminophen is extensively used during pregnancy. But there is a lack of population-representative cohort studies evaluating its effects on a range of neuropsychological and behavioural endpoints. We aimed to assess whether prenatal exposure to acetaminophen is adversely associated with neurodevelopmental outcomes at 1 and 5 years of age.

METHODS

This Spanish birth cohort study included 2644 mother-child pairs recruited during pregnancy. The proportion of liveborn participants evaluated at 1 and 5 years was 88.8% and 79.9%, respectively. Use of acetaminophen was evaluated prospectively in two structured interviews. Ever/never use and frequency of use (never, sporadic, persistent) were measured. Main neurodevelopment outcomes were assessed using Childhood Autism Spectrum Test (CAST), Conner's Kiddie Continuous Performance Test (K-CPT) and ADHD-DSM-IV form list. Regression models were adjusted for social determinants and co-morbidities.

RESULTS

Over 40% of mothers reported using acetaminophen. Ever-exposed offspring had higher risks of presenting more hyperactivity/impulsivity symptoms [incidence rate ratio (IRR) = 1.41, 95% confidence interval (CI) 1.01-1.98), K-CPT commission errors (IRR = 1.10, 1.03-1.17), and lower detectability scores (coefficient β = -0.75, -0.13--0.02). CAST scores were increased in ever-exposed males (β = 0.63, 0.09-1.18). Increased effect sizes of risks by frequency of use were observed for hyperactivity/impulsivity symptoms (IRR = 2.01, 0.95-4.24) in all children, K-CPT commission errors (IRR = 1.32, 1.05-1.66) and detectability (β = -0.18, -0.36-0.00) in females, and CAST scores in males (β = 1.91, 0.44-3.38).

CONCLUSIONS

Prenatal acetaminophen exposure was associated with a greater number of autism spectrum symptoms in males and showed adverse effects on attention-related outcomes for both genders. These associations seem to be dependent on the frequency of exposure.

摘要

背景

对乙酰氨基酚在孕期广泛使用。但缺乏具有人群代表性的队列研究来评估其对一系列神经心理和行为终点的影响。我们旨在评估孕期暴露于对乙酰氨基酚是否与1岁和5岁时的神经发育结局存在不良关联。

方法

这项西班牙出生队列研究纳入了孕期招募的2644对母婴。1岁和5岁时接受评估的活产参与者比例分别为88.8%和79.9%。通过两次结构化访谈前瞻性评估对乙酰氨基酚的使用情况。测量曾经使用/从未使用情况以及使用频率(从不、偶尔、持续)。主要神经发育结局使用儿童自闭症谱系测试(CAST)、康纳儿童连续操作测试(K-CPT)和ADHD-DSM-IV表格清单进行评估。回归模型针对社会决定因素和共病情况进行了调整。

结果

超过40%的母亲报告使用过对乙酰氨基酚。曾经暴露的后代出现多动/冲动症状的风险更高[发病率比(IRR)=1.41,95%置信区间(CI)1.01 - 1.98]、K-CPT的错误率(IRR = 1.10,1.03 - 1.17)以及更低的可检测性得分(系数β = -0.75,-0.13 - -0.02)。曾经暴露的男性CAST得分升高(β = 0.63,0.09 - 1.18)。在所有儿童中,观察到多动/冲动症状的风险效应大小随使用频率增加(IRR = 2.01,0.95 - 4.24),女性中K-CPT的错误率(IRR = 1.32,1.05 - 1.66)和可检测性(β = -0.18,-0.36 - 0.00),以及男性的CAST得分(β = 1.91,0.44 - 3.38)。

结论

孕期暴露于对乙酰氨基酚与男性更多的自闭症谱系症状相关,并对两性与注意力相关的结局显示出不良影响。这些关联似乎取决于暴露频率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验